Efficient long-term cryopreservation of pluripotent stem cells at -80 °C
- PMID: 27694817
- PMCID: PMC5046093
- DOI: 10.1038/srep34476
Efficient long-term cryopreservation of pluripotent stem cells at -80 °C
Abstract
Current long term cryopreservation of cell stocks routinely requires the use of liquid nitrogen (LN2), because commonly used cryopreservation media containing cell membrane permeating cryoprotectants are thermally unstable when frozen at higher storage temperatures, e.g. -80 °C. This instability leads to ice recrystallization, causing progressive loss of cell viability over time under the storage conditions provided by most laboratory deep freezers. The dependency on LN2 for cell storage significantly increases operational expense and raises issues related to impaired working efficiency and safety. Here we demonstrate that addition of Ficoll 70 to cryoprotectant solutions significantly improves system thermal stability at the working temperature (~-80 °C) of laboratory deep freezers. Moreover, a medium comprised of Ficoll 70 and dimethyl sulfoxide (DMSO) in presence or absence of fetal bovine serum (FBS) can provide reliable cryopreservation of various kinds of human and porcine pluripotent stem cells at -80 °C for periods that extend up to at least one year, with the post-thaw viability, plating efficiency, and full retention of pluripotent phenotype comparable to that achieved with LN2 storage. These results illustrate the practicability of a promising long-term cryopreservation method that completely eliminates the need for LN2.
Conflict of interest statement
The intellectual property related to this technology belongs to the University of Missouri, and a USA provisional utility patent application (USA 62/336, 142) has been filed. X.H. as the president of CryoCrate LLC, has obtained an exclusive license from University of Missouri. None of the other authors have any competing financial interests.
Figures
References
-
- Jones J. M. & Thomson J. A. Human embryonic stem cell technology. Seminars in reproductive medicine 18, 219–223 (2000). - PubMed
-
- Odorico J. S., Kaufman D. S. & Thomson J. A. Multilineage differentiation from human embryonic stem cell lines. Stem cells 19, 193–204 (2001). - PubMed
-
- Coopman K. Large-scale compatible methods for the preservation of human embryonic stem cells: current perspectives. Biotechnology progress 27, 1511–1521 (2011). - PubMed
-
- Thirumala S., Goebel W. S. & Woods E. J. Manufacturing and banking of mesenchymal stem cells. Expert opinion on biological therapy 13, 673–691 (2013). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
